Download pdf
Analysis of Different Types of Rabies Treatment Methods
- 1 Wycombe Abbey School Changzhou, No. 9, Huanhu North Road, Xitaihu Street, Changzhou, China
* Author to whom correspondence should be addressed.
Abstract
Rabies is an acute zoonotic infectious disease with a fatality rate of 100%. At present, there is no effective treatment methods and the specific therapeutic effect still needs further analysis. This research will discuss different types of rabies treatment methods and their therapeutic effects. After the onset of rabies, rabies patients and rabid animals may even exhibit aggressive behavior towards others, which is extremely dangerous. RABV is the pathogen that causes rabies. Through continuous exploration, potential drugs against RABV have been discovered. The main drugs known to have inhibitory activity against RABV are ribavirin, amantadine and interferon IFN-α. RNA vaccines are a new type of vaccine that has emerged in recent years. They are the new generation of nucleic acid vaccines. RNA vaccines have the advantages of good safety, high effectiveness and short research and development cycle. The development of new rabies virus vaccine adjuvants that are efficient, low-toxic, safe and inexpensive has become an important field in the current research of rabies vaccines.
Keywords
rabies, treatment, drugs, RNA vaccines
[1]. Shen, Z., Zhao, Y., Zhang, J., et al. (2020) The epidemic status of rabies and research progress of human rabies vaccine. Practical Preventive Medicine, 27(5), 637-641.
[2]. Wang, L., Huang, S., Yang, G. (2020) Discuss the harm and prevention measures of rabies. Journal of animal medicine progress, 2010(S1), 3
[3]. Horiya, M., Posadas-Herrera, G., Takayama-Ito, M., et al. (2022). Genetic Characterization of Human Rabies Vaccine Strain in Japan and Rabies Viruses Related to Vaccine Development from 1940s to 1980s. Viruses, 14(10), 2152.
[4]. Horiya, M., Posadas-Herrera, G., Takayama-Ito, M., et al. (2022). Genetic Characterization of Human Rabies Vaccine Strain in Japan and Rabies Viruses Related to Vaccine Development from 1940s to 1980s. Viruses, 14(10), 2152.
[5]. Liu, X., & Zhu, W. (2021) Research progress on Rabies treatment methods and the Application of Antiviral Drugs. Chinese Journal of Zoonoses, 37(5), 444-449.
[6]. Wang, Y., Miao, F., Zhang, S., et al. (2024) Research progress on RNA vaccines and rabies RNA vaccines. Chinese Journal of Veterinary Medicine, 44(5), 1078-1086.
[7]. Natesan, K., Isloor, S., Vinayagamurthy, B., et al. (2023). Developments in rabies vaccines: the path traversed from Pasteur to the modern era of immunization. Vaccines, 11(4), 756.
[8]. Sui, H., Guo, X., Zhang, Q., et al. (2023) With rabies vaccine and its application research progress. Chinese journal of animal comorbidities, 33(12), 61158-61164.
Cite this article
ZHU,Y.N. (2025). Analysis of Different Types of Rabies Treatment Methods. Theoretical and Natural Science,112,61-65.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of ICEGEE 2025 Symposium: Sensor Technology and Multimodal Data Analysis
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).